Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue
Key PointsJohnson & Johnson currently exhibits a stronger overall revenue profile than Pfizer by maintaining consistently higher absolute sales volume across every reported period.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.